A Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Generalized Myasthenia Gravis

Condition:   Myasthenia Gravis Interventions:   Drug: TAK-079;   Drug: TAK-079 Placebo Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials